Tucker v. Delaware Board of Pharmacy

CourtSuperior Court of Delaware
DecidedNovember 27, 2019
DocketK19A-04-005 NEP
StatusPublished

This text of Tucker v. Delaware Board of Pharmacy (Tucker v. Delaware Board of Pharmacy) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tucker v. Delaware Board of Pharmacy, (Del. Ct. App. 2019).

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

SHEILA P. TUCKER, : C.A. No. K19A-04-005 NEP In and for Kent County Appellant, Vv. DELAWARE BOARD OF PHARMACY, Appellee.

ORDER

Submitted: September 4, 2019 Decided: November 27, 2019

Upon Appeal from the Delaware Board of Pharmacy AFFIRMED

Ciro Poppiti, II, Esquire, Poppiti Law, LLC, Attorney for Appellant Sheila P. Tucker.

Eileen Kelly, Esquire, Department of Justice, Attorney for Appellee Delaware Board

of Pharmacy.

Before the Court is Sheila Tucker’s (hereinafter “Ms. Tucker”) appeal from

the Delaware Board of Pharmacy’s (hereinafter the “Board’’) decision to suspend her

pharmacy license for one year, followed by a three-year license probation. Upon an

extensive review of the record, this Court has determined that the Board had a

substantial basis for its decision and made no errors of law in reaching its

conclusions. Therefore, the Board’s decision is AFFIRMED. I. Factual Background and Procedural History

Ms. Tucker has been a licensed pharmacist for the past thirty-six years, with no prior discipline from the Board. Ms. Tucker has served as President of the Delaware Pharmacists Society and has been active in the Delaware Society of Health System Pharmacists. In 2003, Ms. Tucker opened Market Street Pharmacy (hereinafter the “Pharmacy”) in Wilmington, Delaware, as part of her commitment to serve underserved communities. Ms. Tucker owned and operated the Pharmacy as its pharmacist-in-charge, and leased the building from McConnell Development, Inc.

Over time, the Pharmacy began to decline. On or about July 29, 2016, Respondent informed the Division of Professional Regulation (hereinafter the “DPR”) that she planned to close the Pharmacy by August 8, 2016. On August 1, 2016, the DPR sent a letter to Ms. Tucker providing the legal requirements for closure of a pharmacy under Board of Pharmacy Regulation 4.0.

Ms. Tucker retained closure documents, controlled substances, and patient records in the building as she worked to close down the Pharmacy. McConnell Development terminated Ms. Tucker’s lease on the property on October 31, 2016. At some point between the closure of the Pharmacy and October 2016, Ms. Tucker lost custody of the patient records and controlled substances. Ms. Tucker failed to inform the Board, the Office of Controlled Substances, or the Drug Enforcement Administration that this had occurred.

On or about August 7, 2018, the State of Delaware filed a professional licensure complaint against Ms. Tucker with the Board. In response, Ms. Tucker stipulated with the State that she had “violated each of the statutory and regulatory

provisions cited in the State’s complaint.

' App. to Ms. Tucker’s Opening Br. at A-18. On November 30, 2018, Hearing Officer Roger Akin (hereinafter the “Hearing Officer”) held a hearing on the State’s complaint. The Hearing Officer accepted the stipulated facts and reviewed mitigating evidence from the following individuals: (1) Ms. Tucker; (2) Mr. John Simpson, Ms. Tucker’s former employee and mentee; (3) Senator Margaret Henry, a former state senator; (4) Mr. Christopher Cook, Vice President of Greenhill Pharmacy; (5) Ms. Margaret Tigue, a community activist; and (6) Mr. Kevin Smith, CEO for Habitat for Humanity, New Castle County. The mitigating testimony spoke to Ms. Tucker’s reputation in the community and in the pharmaceutical profession. To summarize the mitigating evidence, the Hearing Officer stated that “there [was] no evidence . . . of any intent on [Ms. Tucker’s] part to cause harm” and that Ms. Tucker had “demonstrated a credible desire to serve the pharmacy needs of underserved, at-risk patients in {Delaware].””

On January 9, 2019, the Hearing Officer recommended the following conclusions of law based upon his factual findings:

(1) Ms. Tucker had violated 24 Del. C. § 2515(a)(6)° by violating Bd. Reg.

4.1.2 (providing that upon permanent closure of pharmacy, certain information must be provided to Executive Secretary of Board of Pharmacy within seven days of closure).

(2) Ms. Tucker had violated 24 Del. C. § 2515(a)(6) by violating Bd. Reg.

4.1.3 (providing that upon permanent closure of pharmacy, person in control of pharmacy must provide newspaper notification of such closure,

including date of closure and to which pharmacy prescriptions will be

transferred). ? Id. at A-27. 3 “A pharmacist licensed under this chapter is subject to disciplinary sanctions set forth in § 2516 of this title if, after a hearing, the Board finds that the pharmacist .... [h]as violated a lawful

provision of this chapter or any lawful regulation established hereunder.” 3 (3) Ms. Tucker had violated 24 Del. C. § 2515(a)(6) by violating Bd. Reg. 4.1.4 (providing that upon permanent closure of pharmacy, person in control of pharmacy must surrender to appropriate authorities his or her pharmacy permit, controlled substances permit, federal controlled substances permit, and all unused 222 Schedule II order forms).

(4) Ms. Tucker had violated 24 Del. C. § 2515(a)(6) by violating Delaware Uniform Controlled Substances Act Regulation (hereinafter “UCSR”) 6.1.2 (providing that those who prescribe or dispense controlled substances must maintain certain records, including name and address of patients to whom prescriptions are administered; dates, names, strengths, and quantity of prescriptions; and whether refills are authorized).

(5) Ms. Tucker had violated 24 Del. C. § 2515(a)(6) by violating UCSR 6.1.3 (providing that dispensing pharmacist must maintain records concerning controlled substances according to applicable federal regulations).

(6) Ms. Tucker had not violated UCSR 6.3.1 (providing that when pharmacist-in-charge leaves position, complete inventory of all controlled substances must be taken by departing pharmacist and arriving pharmacist) since there was no “arriving” pharmacist in this case.

(7) Ms. Tucker had violated 24 Del. C. § 2515(a)(6) by violating UCSR 6.3.2 (providing that pharmacist closing practice must notify Office of Controlled Substances within thirty days of such decision, and provide Office with inventory of controlled substances “on hand”).

(8) Ms. Tucker had violated 24 Del. C. § 2515(a)(6) by violating UCSR 6.4 (providing that pharmacist must retain all records “required by” Uniform

Controlled Substances rules for at least two years). (9) Ms. Tucker had violated 24 Del. C. § 2515(a)(2).!

The Hearing Officer recommended a two-year suspension of Ms. Tucker’s pharmacy license, stayed immediately in lieu of a three-year license probation. The Hearing Officer recommended that Ms. Tucker be subject to various requirements as part of this probation.

On February 20, 2019, the Board held a hearing on Ms. Tucker’s case and voted unanimously to accept the Hearing Officer’s conclusions of law. However, the Board rejected the Hearing Officer’s discipline recommendation and instead imposed a license suspension for one year, followed by a three-year period of probation. The Board issued its final order on March 20, 2019. Ms. Tucker filed a timely Notice of Appeal on April 17, 2019, challenging the discipline ordered by the Board.

Il. Standard of Review

On appeal from an administrative board’s final order, the appellate court must determine whether the board’s decision was supported by “substantial evidence”? and that the board “made no errors of law.’® Substantial evidence is “such relevant evidence as a reasonable mind might accept as adequate to support a conclusion.”

The appellate court must review the record in a manner “most favorable to the

prevailing party below.”® The appellate court does not weigh the evidence or make

Free access — add to your briefcase to read the full text and ask questions with AI

Related

National Cash Register v. Riner
424 A.2d 669 (Superior Court of Delaware, 1980)
Johnson v. Chrysler Corporation
213 A.2d 64 (Supreme Court of Delaware, 1965)
Anchor Motor Freight v. Ciabattoni
716 A.2d 154 (Supreme Court of Delaware, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Tucker v. Delaware Board of Pharmacy, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tucker-v-delaware-board-of-pharmacy-delsuperct-2019.